AstraZeneca eyes up transition to eco-friendly inhaler propellant
AstraZeneca has completed all clinical studies required to support the first filings for the transition of its chronic obstructive pulmonary …
Post
-
-
GSK reports results from Phase III trials of drug candidate for severe asthma
UK-based pharmaceutical company GSK has announced results from two Phase III clinical trials of depemokimab in patients with severe asthma …
-
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
German pharmaceutical company Boehringer Ingelheim has reported positive outcomes from the first cohort of Beamion LUNG-1, a two-part trial analysing …
-
FDA authorises US trial of Rezolute’s drug candidate for congenital hyperinsulinism
The US Food and Drug Administration (FDA) has lifted the partial clinical holds preventing Rezolute’s RZ358 (ersodetug) from being investigated …
-
Terns Pharmaceuticals reports positive data from Phase I trial of obesity treatment
US-based biopharmaceutical company Terns Pharmaceuticals has reported positive topline results from its Phase I clinical trial of TERN-601, a once-daily …
-
Testosterone could influence men’s immune response to Covid-19
According to the World Health Organization, there have been over 760 million cases and 6.9 million deaths of Covid-19 globally …
-
AstraZeneca eyes up transition to eco-friendly inhaler propellant
AstraZeneca has completed all clinical studies required to support the first filings for the transition of its chronic obstructive pulmonary …
-
GSK reports results from Phase III trials of drug candidate for severe asthma
UK-based pharmaceutical company GSK has announced results from two Phase III clinical trials of depemokimab in patients with severe asthma …
-
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
German pharmaceutical company Boehringer Ingelheim has reported positive outcomes from the first cohort of Beamion LUNG-1, a two-part trial analysing …
-
FDA authorises US trial of Rezolute’s drug candidate for congenital hyperinsulinism
The US Food and Drug Administration (FDA) has lifted the partial clinical holds preventing Rezolute’s RZ358 (ersodetug) from being investigated …
-
Terns Pharmaceuticals reports positive data from Phase I trial of obesity treatment
US-based biopharmaceutical company Terns Pharmaceuticals has reported positive topline results from its Phase I clinical trial of TERN-601, a once-daily …
-
Summit’s checkpoint inhibitor trumps Keytruda in lung cancer trial
Summit Therapeutics’s drug ivonescimab reduced the risk of lung cancer progression or death by nearly half, compared to MSD’s blockbuster …
-
Sickle cell in September: spreading awareness and supporting solutions
Sickle cell disease (SCD) is a genetic blood disorder characterised by abnormally shaped red blood cells. The disease leads to …
-
EASD24: PolTREG’s T cell therapy shows long-term remission in type 1 diabetes
PolTREG has presented positive long-term data for its cell therapy, PTG-007, showing that the therapy induced clinical remission for type …
-
Study shows high HIV burden in vulnerable Brazilian youth population
In Brazil, the disproportionate impact of human immunodeficiency virus (HIV) on young men who have sex with men (YMSMs) has …
